Apellis Pharmaceuticals Inc (NQ: APLS )

35.86 USD +0.06 (+0.17%)

Official Closing Price Updated: 4:54 PM EDT, Oct 26, 2020 Add to My Watchlist

Price and Volume

Volume	426,100
Open	35.15
Bid (Size)	35.80 (2)
Ask (Size)	35.88 (20)
Prev. Close	35.80
Today's Range	34.54 - 36.09
52wk Range	16.85 - 45.04
Shares Outstanding	55,941,896
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Apellis Announces 18-Month Data from Phase 1b Study of Pegcetacoplan in Patients with Geographic Atrophy (GA)

October 19, 2020

Apellis Announces New Data Demonstrating Correlation between Complement Activation and COVID-19 Severity

October 15, 2020

Performance

YTD	+15.06%	+15.06%
1 Month	+20.09%	+20.09%
3 Month	+25.87%	+25.87%
6 Month	-6.83%	-6.83%
1 Year	+24.47%	+24.47%

More News

Apellis to Present Positive Results from the Phase 2 DISCOVERY Study of Pegcetacoplan in C3 Glomerulopathy (C3G) at ASN Kidney Week

October 09, 2020

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 07, 2020

Apellis Initiates Registrational Programs of Pegcetacoplan in Patients with C3G / IC-MPGN and ALS, Rare Diseases with High Unmet Need

October 05, 2020

Apellis Announces New Analysis Demonstrating Targeted C3 Therapy Pegcetacoplan Slows Progression of Early Disease in Patients with Geographic Atrophy (GA)

October 03, 2020

Apellis Pharmaceuticals to Present at Stifel’s 2020 Immunology and Inflammation Virtual Summit

September 24, 2020

Apellis Announces Late-Breaking Presentation of Targeted C3 Therapy Pegcetacoplan in Patients with Geographic Atrophy (GA) at EURETINA 2020

September 21, 2020

Apellis Announces Submission of Pegcetacoplan Marketing Applications to FDA and EMA for Patients with PNH

September 15, 2020

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 04, 2020

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

September 02, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.